Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Patent
1985-08-09
1987-06-30
Kight, John
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
530380, 530412, 530829, A61L 200, A61K 3514, A61K 3702, A61K 39395
Patent
active
046771948
ABSTRACT:
An endotoxin inactivator is isolated from human plasma by anion exchange (DEAE-Sephadex), dye-affinity (Cibracron Blue-Sepharose), and adsorption (on hydroxyapatite) chromatography. The endotoxin inactivator, isolated in essentially pure form, may be used to depyrogenate clinical blood products.
REFERENCES:
patent: 4382028 (1983-05-01), Paget
Skarnes et al., J. Exp. Med., vol. 108, (1958), pp. 685-700.
Landy et al., J. Exp. Med., vol. 110 (1959), pp. 731-750.
Johnson et al., Amer. Journ. of Path., vol. 88, No. 3, (1977), pp. 559-574.
CA vol. 72, 1970, 88461w, Inoue et al.
Tewksbury et al., "Purification of Human Angiotensinogen", Supp. II, Circ. Res., vol. 41, No. 4, Oct. 1977, pp. II-29-II-33.
Biotech Research Laboratories, Inc.
Cooper Iver P.
Kight John
Nutter Nathan M.
LandOfFree
Isolation of an endotoxin inactivator from human plasma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolation of an endotoxin inactivator from human plasma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolation of an endotoxin inactivator from human plasma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-448505